Cargando…
Incidence and Burden of the Myelodysplastic Syndromes
Since 2001, cases of myelodysplastic syndromes (MDSs) have been tracked by cancer registries. Examining registry data in the USA, the reported age-adjusted incidence of MDS per 100,000 was 3.3 per year for 2001–2003 and 4.9 per year for 2007–2011, with increases likely a result of growing awareness...
Autor principal: | Cogle, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553145/ https://www.ncbi.nlm.nih.gov/pubmed/26134527 http://dx.doi.org/10.1007/s11899-015-0269-y |
Ejemplares similares
-
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
por: Bejar, Rafael
Publicado: (2015) -
Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
por: Drusbosky, Leylah M., et al.
Publicado: (2017) -
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
por: Clichet, Valentin, et al.
Publicado: (2023) -
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
por: Teichman, Jennifer, et al.
Publicado: (2022) -
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
por: Karantanos, Theodoros, et al.
Publicado: (2022)